Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes-Reference-Cited by-同舟云学术

Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes

Published:2018-11-12 Issue:8 Volume:26 Page:1516-1530
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Jiao Yuhao,Davis Joanne E.,Rautela Jai^ORCID,Carrington Emma M.,Ludford-Menting Mandy J.,Goh Wilford,Delconte Rebecca B.,Souza-Fonseca-Guimaraes Fernando,Koldej Rachel,Gray Daniel,Huang David,Kile Ben T.^ORCID,Lew Andrew M.,Ritchie David S.,Huntington Nicholas D.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-018-0228-y.pdf

Reference39 articles.

1. Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015;2:e91–100.

2. Wong E, Mason K, Collins J, Hockridge B, Boyd J, Gorelik A, et al. The prognostic limitations of donor T-cell chimerism after myeloablative allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2017;23:840–4.

3. Negrin RS. Graft-versus-host disease versus graft-versus-leukemia. Hematol Am Soc Hematol Educ Program. 2015;2015:225–30.

4. Teshima T, Reddy P, Zeiser R. Acute graft-versus-host disease: novel biological insights. Biol Blood Marrow Transplant. 2016;22:11–16.

5. Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2017;35:1154–61.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies;Cancers;2024-01-26

2. Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD;Biology;2023-04-25

3. Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews;International Journal of Clinical Practice;2022-10-07

4. Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy;Cell Death Discovery;2022-01-10

5. Treatment of AML Relapse After Allo-HCT;Frontiers in Oncology;2021-12-16